持続グルコースモニタリングデバイスの市場規模、シェア、成長分析：コンポーネント別、接続性別、最終用途別、地域別 - 産業予測 2025～2032年

持続グルコースモニタリングデバイス 2023年の市場規模は86億7,000万米ドルで、2024年の98億4,000万米ドルから2032年には271億米ドルに成長し、予測期間中（2025～2032年）のCAGRは13.5％で成長する見通しです。

糖尿病市場は、有病率の上昇と持続グルコースモニタリング（CGM）デバイスの採用増加によって著しい成長を遂げています。国際糖尿病連合は、2022年に約5億3,660万人が糖尿病と診断されたと報告し、この数字は2030年までに6億4,280万人、2045年までに7億8,370万人に増加すると予測しています。CGMデバイスは、食事行動、服薬遵守、身体活動に関する重要なデータを提供するだけでなく、高度なデジタル治療ソリューションを通じて、メーカーと患者の関係を改善します。数多くのアプリケーションがCGMデータを統合して動向を分析し、ライフスタイルの変更を推奨することで、患者の転帰を総合的に向上させ、CGMデバイス市場の成長軌道を後押ししています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術の進歩
• 規制情勢
• 顧客と購買基準の分析
• 特許分析

持続グルコースモニタリングデバイス市場規模：コンポーネント別

• 市場概要
• 送信機
• センサー
• 受信機

持続グルコースモニタリングデバイス市場規模：接続性別

• 市場概要
• Bluetooth
• 4G
• その他

持続グルコースモニタリングデバイス市場規模：最終用途別

• 市場概要
• 病院
• ホームケア

持続グルコースモニタリングデバイス市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Abbott Laboratories（USA）
• Dexcom, Inc.（USA）
• Medtronic PLC（Ireland）
• Roche（Switzerland）
• Senseonics Holdings, Inc.（USA）
• GlySens Incorporated（USA）
• Novo Nordisk A/S（Denmark）
• Insulet Corporation（USA）
• Tandem Diabetes Care, Inc.（USA）
• Ascensia Diabetes Care Holdings AG（Switzerland）
• Ypsomed AG（Switzerland）
• Menarini Diagnostics（Italy）
• Nemaura Medical Inc.（UK）
• Medisana GmbH（Germany）
• Sanofi（France）
• Johnson & Johnson（USA）
• Braun Melsungen AG（Germany）
• Arkray, Inc.（Japan）
• Terumo Corporation（Japan）
• MicroTech Medical（China）

結論と提言

Continuous Glucose Monitoring Devices Market size was valued at USD 8.67 billion in 2023 and is poised to grow from USD 9.84 billion in 2024 to USD 27.1 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).

The diabetes market is witnessing significant growth driven by the rising prevalence of the condition and the increasing adoption of continuous glucose monitoring (CGM) devices. The International Diabetes Federation reported that around 536.6 million people were diagnosed with diabetes in 2022, with estimates predicting this figure will rise to 642.8 million by 2030 and 783.7 million by 2045. CGM devices not only provide critical data on dietary behaviors, medication adherence, and physical activity but also foster improved relationships between manufacturers and patients through advanced digital therapeutic solutions. Numerous applications integrate CGM data to analyze trends and recommend lifestyle changes, collectively enhancing patient outcomes and propelling the growth trajectory of the CGM device market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Continuous Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Continuous Glucose Monitoring Devices Market Segments Analysis

Global Continuous Glucose Monitoring Devices Market is segmented by Component, Connectivity, End-use and region. Based on Component, the market is segmented into Transmitters, Sensors and Receivers. Based on Connectivity, the market is segmented into Bluetooth, 4G and Others. Based on End-use, the market is segmented into Hospitals and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Continuous Glucose Monitoring Devices Market

The rising incidence of diabetes worldwide serves as a crucial catalyst for the growth of the Continuous Glucose Monitoring (CGM) Devices market. As the number of individuals managing diabetes continues to climb, there is an urgent need for reliable monitoring and management technologies. Continuous glucose monitoring devices provide real-time feedback, enabling better control of blood sugar levels and improving overall health outcomes for patients. This demand drives innovation and investment in CGM technology, fostering advancements that enhance user experience and accuracy. Consequently, the market for these devices is positioned for substantial growth, addressing the critical needs of an expanding population affected by diabetes.

Restraints in the Continuous Glucose Monitoring Devices Market

Despite advancements in the accuracy of continuous glucose monitoring devices, they can occasionally display discrepancies when compared to traditional blood glucose testing methods. This inconsistency raises concerns among users who rely on precise measurements for managing their health. Such reliability issues can lead to diminished trust in the devices, prompting some individuals to prefer conventional testing approaches. As a result, the perceived accuracy challenges of these innovative tools may become a significant restraint within the market, potentially affecting adoption rates and user satisfaction. Addressing these discrepancies is essential for manufacturers to enhance user confidence and expand market reach.

Market Trends of the Continuous Glucose Monitoring Devices Market

The Continuous Glucose Monitoring (CGM) Devices market is witnessing a significant trend towards integration with digital health platforms, enhancing user experience and data management. This integration allows individuals with diabetes to effortlessly monitor their glucose levels alongside other vital health metrics, facilitating a comprehensive approach to health management. Through mobile applications and cloud-based systems, users can access real-time data, receive personalized insights, and share information with healthcare providers, improving communication and care outcomes. As consumers increasingly seek connected health solutions, this trend is likely to drive growth in the CGM market, fostering innovation and expanding the overall digital health ecosystem.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Patent Analysis

Global Continuous Glucose Monitoring Devices Market Size by Component & CAGR (2025-2032)

• Market Overview
• Transmitters
• Sensors
• Receivers

Global Continuous Glucose Monitoring Devices Market Size by Connectivity & CAGR (2025-2032)

• Market Overview
• Bluetooth
• 4G
• Others

Global Continuous Glucose Monitoring Devices Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Homecare

Global Continuous Glucose Monitoring Devices Market Size & CAGR (2025-2032)

• North America (Component, Connectivity, End-use)
  • US
  • Canada
• Europe (Component, Connectivity, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Connectivity, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Connectivity, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Connectivity, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Senseonics Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlySens Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Diagnostics (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemaura Medical Inc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisana GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTech Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations